Literature DB >> 3485196

Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.

I M Ramzan, G Levy.   

Abstract

Seizures, often with fatal outcome, are a manifestation of pronounced theophylline intoxication. The purpose of this investigation was to characterize the relationship between theophylline concentrations and theophylline-induced convulsions and to develop an animal model suitable for exploring conditions that might predispose theophylline-treated individuals to seizures. Female Lewis rats (approximately 170 g) received an i.v. infusion of theophylline (as aminophylline) at one of three different rates (1.03-5.1 mg/min/rat) until the animals exhibited a maximal seizure (which occurred after 11 +/- 1 to 42 +/- 3 min of infusion). The total dose, the serum concentration (both total and unbound drug) and the brain concentration of theophylline at onset of seizures increased with increasing infusion rate. The theophylline concentration in cerebrospinal fluid at onset of seizures (mean +/- S.D., 232 +/- 17 mg/l, n = 41) was not affected by the infusion rate. The theophylline metabolites 1-methyluric acid and 1,3-dimethyluric acid were found in serum but at very much lower concentrations than those of theophylline. 1-Methylxanthine and caffeine were not detected in any serum sample, 3-methylxanthine was present in low concentrations in only some serum samples and 1-methyluric acid and 3-methylxanthine were found in the brain in low concentrations (less than 10 mg/kg). Theophylline metabolites were not detected in cerebrospinal fluid. Direct i.v. infusion of either 1-methyluric acid, 1,3-dimethyluric acid or 3-methylxanthine did not produce seizures despite high concentrations in serum. Ethylenediamine infusions also did not cause seizures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485196

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.

Authors:  A Dupuis; W Couet; J Paquereau; S Debarre; A Portron; C Jamois; S Bouquet
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Development of a new quantitative approach for the isobolographic assessment of the convulsant interaction between pefloxacin and theophylline in rats.

Authors:  L M Levasseur; A Delon; W R Greco; P Faury; S Bouquet; W Couet
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats.

Authors:  Miren Cadart; Sandrine Marchand; Claudine Pariat; Serge Bouquet; William Couet
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

4.  Novel N-methylated 8-oxoisoguanines from Pacific sponges with diverse neuroactivities.

Authors:  Tsuyoshi Sakurada; Martin B Gill; Shanti Frausto; Bryan Copits; Keiichi Noguchi; Keiko Shimamoto; Geoffrey T Swanson; Ryuichi Sakai
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

5.  A recursive-partitioning model for blood-brain barrier permeation.

Authors:  S R Mente; F Lombardo
Journal:  J Comput Aided Mol Des       Date:  2005-12-06       Impact factor: 3.686

6.  Effect of renal or hepatic dysfunction on neurotoxic convulsion induced by ranitidine in mice.

Authors:  M Shimokawa; K Yamamoto; J Kawakami; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

7.  Pharmacodynamics of zoxazolamine and chlorzoxazone in rats.

Authors:  M Yasuhara; G Levy
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

8.  Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.

Authors:  A Hoffman; G Levy
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

9.  The effect of immunosuppression by total-body irradiation on the pharmacodynamics of centrally active drugs in rats.

Authors:  A Hoffman; J Alfon; G Habib; E Pinto; R Gorodetsky
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

10.  Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure.

Authors:  J Dingemanse; F A Sollie; D D Breimer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.